Big board pick. NVS. Novartis drug Signifor® gai
Post# of 97772
![Avatar](/images/ProfileImages/934136062_182_A_Dawgg 1 Two 10-baggers at the same time..jpg)
Big board pick. NVS.
Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder
- As the only pituitary-directed therapy, Signifor represents a novel therapeutic approach by addressing the underlying mechanism of Cushing's disease(1)
- In the Phase III trial, most patients experienced a sustained decrease in mean urinary-free cortisol levels, a key measure of disease, with a subset normalizing(2)
- In the EU, Signifor has been previously approved for the treatment of adult patients with Cushing's disease; other worldwide regulatory filings are underway
http://finance.yahoo.com/news/multimedia-asse...00498.html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)